Natus Medical Incorporated

Informe acción NasdaqGS:NTUS

Capitalización de mercado: US$1.1b

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Natus Medical Crecimiento futuro

Future controles de criterios 3/6

Información clave

58.9%

Tasa de crecimiento de los beneficios

58.1%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Medical Equipment16.6%
Tasa de crecimiento de los ingresos4.4%
Rentabilidad financiera futuran/a
Cobertura de analistas

Low

Última actualizaciónn/a

Actualizaciones recientes sobre el crecimiento futuro

Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)

May 05
Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)

Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)

Jan 11
Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)

Recent updates

Novanta to replace Six Flags Entertainment in S&P MidCap 400, Six Flags to replace Natus Medical in S&P SmallCap 600

Jul 22

Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital

Mar 04
Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital

Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital

Nov 08
Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital

We Like Natus Medical's (NASDAQ:NTUS) Earnings For More Than Just Statutory Profit

Aug 13
We Like Natus Medical's (NASDAQ:NTUS) Earnings For More Than Just Statutory Profit

Does Natus Medical (NASDAQ:NTUS) Have A Healthy Balance Sheet?

Aug 02
Does Natus Medical (NASDAQ:NTUS) Have A Healthy Balance Sheet?

We Think Shareholders Are Less Likely To Approve A Pay Rise For Natus Medical Incorporated's (NASDAQ:NTUS) CEO For Now

Jun 10
We Think Shareholders Are Less Likely To Approve A Pay Rise For Natus Medical Incorporated's (NASDAQ:NTUS) CEO For Now

Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)

May 05
Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)

Is Natus Medical (NASDAQ:NTUS) Using Debt Sensibly?

Feb 15
Is Natus Medical (NASDAQ:NTUS) Using Debt Sensibly?

Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)

Jan 11
Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)

Reflecting on Natus Medical's (NASDAQ:NTUS) Share Price Returns Over The Last Five Years

Dec 07
Reflecting on Natus Medical's (NASDAQ:NTUS) Share Price Returns Over The Last Five Years

Previsiones de crecimiento de beneficios e ingresos

NasdaqGS:NTUS - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/202351745N/AN/A1
12/31/202249534N/AN/A1
3/31/2022478134448N/A
12/31/2021473136064N/A
9/30/2021464176569N/A
6/30/202145226569N/A
3/31/2021421-113642N/A
12/31/2020416-172634N/A
9/30/2020428-192029N/A
6/30/2020449-13646N/A
3/31/2020490116471N/A
12/31/2019495-165560N/A
9/30/2019505-305562N/A
6/30/2019512-443846N/A
3/31/2019517-502533N/A
12/31/2018531-232433N/A
9/30/2018521-181724N/A
6/30/2018513-211421N/A
3/31/2018505-241925N/A
12/31/2017501-201620N/A
9/30/2017477-31518N/A
6/30/2017445194750N/A
3/31/2017419345255N/A
12/31/2016382436973N/A
9/30/2016374416770N/A
6/30/2016378394650N/A
3/31/2016374383742N/A
12/31/201537638N/A37N/A
9/30/201537040N/A44N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: NTUS's forecast earnings growth (58.9% per year) is above the savings rate (1.9%).

Beneficios vs. Mercado: NTUS's earnings (58.9% per year) are forecast to grow faster than the US market (13.1% per year).

Beneficios de alto crecimiento: NTUS's earnings are expected to grow significantly over the next 3 years.

Ingresos vs. Mercado: NTUS's revenue (4.4% per year) is forecast to grow slower than the US market (8% per year).

Ingresos de alto crecimiento: NTUS's revenue (4.4% per year) is forecast to grow slower than 20% per year.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Insufficient data to determine if NTUS's Return on Equity is forecast to be high in 3 years time


Descubre empresas en crecimiento